Clinical trials
Dyslipidemias trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 8 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 11 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 13 |
| 2019 | 14 |
| 2020 | 9 |
| 2021 | 12 |
| 2022 | 13 |
| 2023 | 10 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 144 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Toronto | 5 |
| Chong Kun Dang Pharmaceutical | 4 |
| German Institute of Human Nutrition | 4 |
| IlDong Pharmaceutical Co Ltd | 4 |
| John Sievenpiper | 4 |
| Aga Khan University | 3 |
| Assiut University | 3 |
| Daewoong Pharmaceutical Co. LTD. | 3 |
| Yooyoung Pharmaceutical Co., Ltd. | 3 |
| Azienda Ospedaliera Universitaria Integrata Verona | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 144 |
| Hypertension | 51 |
| Obesity | 39 |
| Diabetes Mellitus | 30 |
| Cardiovascular Diseases | 26 |
| Metabolic Syndrome | 24 |
| Diabetes Mellitus, Type 2 | 20 |
| Insulin Resistance | 13 |
| Non-alcoholic Fatty Liver Disease | 13 |
| Prediabetic State | 13 |
Trials
Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.